| Literature DB >> 31614790 |
Mingliu Wang1, Pengcheng Du2, Jianping Wang3, Ruiting Lan4, Jun Huang5, Ming Luo6, Yan Jiang7, Jun Zeng8, Yi Quan9, Zhaohui Shi10, Han Zheng11.
Abstract
Streptococcus suis is an important zoonotic pathogen. Serotype 2 and sequence type (ST) 1 are the most frequently reported strains in both infected humans and pigs. ST7 is only endemic to China, and it was responsible for outbreaks in 1998 and 2005 in China. In the present study, 38 sporadic ST7 S. suis strains, which mostly caused sepsis, were collected from patients in the Guangxi Zhuang Autonomous Region (GX) between 2007 and 2018. Of 38 sporadic ST7 strains, serotype 14 was the most frequent (27 strains, 71.1%), followed by serotype 2 (11 strains, 28.9%). The phylogenetic structure of the ST7 population, including epidemic and sporadic ST7 strains, was constructed using mutational single-nucleotide polymorphisms (SNPs). High diversity within the ST7 population was revealed and divided into five lineages. Only one sporadic ST7 strain, GX14, from a Streptococcal toxic-shock-like syndrome (STSLS) patient was clustered into the same lineage as the epidemic strains. GX14 and the epidemic strains diverged in 1974. The sporadic ST7 strains of GX were mainly clustered into lineage 5, which emerged in 1980. Comparing to genome of epidemic strain, the major differences in genome of sporadic ST7 strains of GX was the absence of 89 kb pathogenicity island (PAI) specific to epidemic strain and insertion of 128 kb ICE_phage tandem MGE or ICE portion of the MGE. These mobile elements play a significant role in the horizontal transfer of antibiotic resistance genes in sporadic ST7 strains. Our results enhanced the understanding of the evolution of the ST7 strains and their ability to cause life-threatening infections in humans.Entities:
Keywords: Streptococcus suis; comparative genomes; phylogenetic structure; sequence type 7; serotype 14; sporadic strain
Year: 2019 PMID: 31614790 PMCID: PMC6963630 DOI: 10.3390/pathogens8040187
Source DB: PubMed Journal: Pathogens ISSN: 2076-0817
Figure 1A maximum-likelihood phylogenetic tree of ST7 population strains based on mutational SNPs differences across the whole core genome. The ST1 strain LOLA-SS002 was used as an outgroup to root the tree. The strains are colored on based on the regions of the isolation. Red is Sichuan Province, purple is Jiangsu Province and green is GX. Serotype 14 and tet(M) gene were colored in pink and orange red, respectively. The dates shown in red are the median estimates for the indicated nodes and corresponding 95% confidence intervals, taken from the results of the BEAST analysis. The bootstrap values were added in each node in black. The scale is given as the number of substitutions per variable site.
Figure 2The geographic spread of the sporadic ST7 strains of GX. Strains of different lineages are indicated in different colors (lineage 1, 2, 3, 4a, 5a and 5b is green, orange, purple, brown, yellow and red, respectively). Stars in different colors on the map represent serotype 2 isolated in different years; Cycles in different colors on the map represent serotype 14 isolated in different years.
Figure 3(A). Mauve alignment and structure variation of the genome of sporadic ST7 GX14 and epidemic strain SC84. The syntenic regions and unique regions in the genomes are shown as corresponding colored areas. The inner and outer circle is GX14 and SC84, respectively. (B). Schematic comparison of 72K PAI in the study and 89K PAI. The direction of the arrow indicates the direction of transcription. Regions of >70% identity were marked by blue shading. The AR genes, 2-component signal-transduction systems, type IV secretion system, lantibiotic biosynthesis cluster and ABC transport system were indicated by different colors. Tn916 was highlighted in a black box. The att sites are located in the flanking region of PAIs.
Figure 4(A). Mauve alignment and structure variation of the genome of sporadic ST7 GX25, GX28 and epidemic strain SC84. The syntenic regions and unique regions in the genomes are shown as corresponding colored areas. (B). Schematic comparison of ICEs and ICE-phage tandem MGE in the study. The direction of the arrow indicates the direction of transcription. Regions of >70% identity were marked by blue shading. The AR genes were indicated by different colors. ICE and phage were highlighted in a red and black box, respectively.
The information of strains used in the study.
| Lineage | Strain Name | Accession No. | City | Year | Symptom | PAI/GI | PEN G (BP: > 4 μg/mL) | CEF (BP: > 4 μg/mL) | TET (BP: > 8 μg/mL) | ERY (BP: > 1 μg/mL) | AZI (BP: >1 μg/mL) | CLI (BP: > 1 μg/mL) | STR (BP: > 250 μg/mL) | KAN (BP: > 250 μg/mL) | SPE (BP: > 256 μg/mL) | GEN (BP: > 250 μg/mL) | TRI (BP *: > 4 μg/mL) | Antibiotic Resistance Genes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lineage 1 | GX49 | SRR8523142 | Beihai | 2015 | Sepsis | ICESsuGX88 | 0.064 | 0.047 | 16 | 0.19 | 0.38 | 0.5 | 2 | 6 | 32 |
|
| |
| GX88 | SRR8523131 | Qinzhou | 2018 | Meningitis | ICESsuGX88 | 0.064 | 0.064 | 24 | 48 | >256 | >256 | 2 | 4 | 32 | 4 | 0.75 * | ||
| Lineage 2 | GX47 | SRR8523138 | Yulin | 2014 | Sepsis | ICESsuGX88 | 0.064 | 0.064 | 24 | >256 | >256 | >256 | 4 | 3 | 32 | 6 | 3 * | |
| Lineage 3 | GX79 | SRR8523125 | Beihai | 2017 | Meningitis | / | 0.047 | 0.047 | 24 | >256 | >256 | >256 | >1024 | >256 | 16 | 12 | 0.5 * | |
| Lineage 4a | GX14 | SRR8523149 | Qinzhou | 2008 | STSLS | 72K | 0.094 | 0.047 | 24 | 0.19 | 0.38 | 0.38 | >1024 | 8 | 24 | 8 | 0.75 * | |
| Lineage 5a | GX18 | SRR8523148 | Yulin | 2011 | Sepsis | ICESsuGX81 | 0.094 | 0.125 | 24 | 0.75 | 0.75 | 0.75 | 3 | 6 | 24 | 8 | 0.5 * | |
| GX21 | SRR8523152 | Yulin | 2012 | Sepsis | CMGETZ080501 | 0.032 | 0.064 | 24 | >256 | >256 | >256 | 512 | >256 | 16 | 8 | 0.75 * | ||
| GX22 | SRR8523135 | Chongzuo | 2012 | Sepsis | CMGEGX22 | 0.047 | 0.064 | 32 | >256 | >256 | >256 | >1024 | >256 | 24 | 4 | 0.25 * | ||
| GX98 | SRR8523127 | Guilin | 2016 | / | CMGEGX22 | 0.047 | 0.047 | 24 | >256 | >256 | >256 | >1024 | >256 | 16 | 6 | 0.38 * | ||
| GX9 | SRR8523146 | Guigang | 2007 | Meningitis | CMGETZ080501 | 1.5 | 2 | 16 | >256 | >256 | >256 | >1024 | >256 | 24 | 3 | >32 * | ||
| GX25 | SRR8523133 | Yulin | 2012 | Sepsis | CMGETZ080501 | 0.047 | 0.064 | 16 | >256 | >256 | >256 | >1024 | >256 | 24 | 6 | 3 * | ||
| Lineage 5b | GX24 | SRR8523136 | Yulin | 2012 | Meningitis | ICESsuGX81 | 0.064 | 0.094 | 16 | >256 | >256 | >256 | 2 | 3 | 24 | 6 | 0.75 * | |
| GX37 | SRR8523140 | Guigang | 2014 | Sepsis | ICESsuGX81 | 0.047 | 0.094 | 24 | 0.75 | 0.75 | 0.5 | 6 | 4 | 48 | 8 | 0.5 * | ||
| GX89 | SRR8523132 | Guigang | 2018 | Meningitis | ICESsuGX81 | 0.064 | 0.064 | 24 | 0.5 | 0.5 | 0.75 | 2 | 3 | 24 | 2 | 0.38 * | ||
| GX91 | SRR8523117 | Liuzhou | 2018 | / | ICESsuGX81 | 0.047 | 0.064 | 16 | >256 | >256 | >256 | >1024 | 12 | >1024 | 4 | 0.38 * | ||
| GX50 | SRR8523121 | Beihai | 2015 | Sepsis | ICESsuGX81 | 0.064 | 0.38 | 12 | 0.125 | 0.25 | 0.5 | 2 | 4 | 24 | 6 | 0.75 * | ||
| GX80 | SRR8523124 | Qinzhou | 2017 | Meningitis | ICESsuGX81 | 0.047 | 0.125 | 12 | >256 | >256 | >256 | 2 | 4 | 24 | 4 | 0.75 * | ||
| GX48 | SRR8523141 | Yulin | 2015 | Sepsis | ICESsuGX81 | 0.064 | 0.064 | 16 | 0.5 | 0.75 | 0.75 | 6 | 8 | 24 | 8 | 1 * | ||
| GX27 | SRR8523134 | Yulin | 2012 | Sepsis | ICESsuGX81 | 0.064 | 0.125 | 16 | 0.38 | 0.38 | 0.75 | 2 | 2 | 48 | 4 | 0.5 * | ||
| GX70 | SRR8523118 | Beihai | 2016 | Sepsis | ICESsuGX81 | 0.047 | 0.19 | 16 | 0.38 | 0.5 | 0.75 | 2 | 2 | 32 | 4 | 0.19 * | ||
| GX85 | SRR8523115 | Qinzhou | 2018 | Meningitis | ICESsuGX81 | 0.064 | 0.064 | 16 | 0.75 | 0.75 | 0.75 | 2 | 3 | 48 | 4 | 1 * | ||
| GX81 | SRR8523123 | Nanning | 2017 | Sepsis | ICESsuGX81 | 0.094 | 0.094 | 12 | 48 | >256 | >256 | 8 | 12 | 24 | 6 | 2 * | ||
| GX87 | SRR8523130 | Qinzhou | 2018 | Sepsis | ICESsuGX81 | 0.047 | 0.094 | 24 | >256 | >256 | >256 | >1024 | >256 | 32 | >256 | 0.25 * | ||
| GX16 | SRR8523150 | Yulin | 2010 | Sepsis | ICESsuGX81 | 0.094 | 0.064 | 16 | 0.75 | 0.75 | 0.75 | 2 | 2 | 32 | 4 | 0.38 * | ||
| GX39 | SRR8523137 | Yulin | 2014 | / | ICESsuGX81 | 0.064 | 0.064 | 16 | >256 | >256 | >256 | >1024 | >256 | 16 | >256 | >32 * | ||
| GX8 | SRR8523145 | Yulin | 2007 | Sepsis | ICESsuGX81 | 0.094 | 0.094 | 12 | >256 | >256 | >256 | 3 | 8 | 24 | 6 | 0.25 * | ||
| GX11 | SRR8523143 | Yulin | 2008 | Sepsis | ICESsuGX81 | 0.094 | 0.094 | 24 | 0.75 | 0.75 | 0.5 | 3 | 8 | 32 | 6 | 1 * | ||
| GX13 | SRR8523144 | Yulin | 2008 | Meningitis | ICESsuGX81 | 0.064 | 0.094 | 24 | >256 | >256 | >256 | 4 | 6 | 32 | 4 | 0.25 * | ||
| GX17 | SRR8523147 | Yulin | 2010 | Sepsis | ICESsuGX81 | 0.064 | 0.094 | 16 | 0.5 | 0.5 | 0.75 | 8 | 6 | 32 | 3 | 0.094 * | ||
| GX83 | SRR8523122 | Nanning | 2017 | Sepsis | ICESsuGX81 | 0.094 | 0.094 | 12 | 0.75 | 0.75 | 0.38 | 4 | 6 | 24 | 8 | 3 * | ||
| GX19 | SRR8523151 | Yulin | 2011 | Meningitis | ICESsuGX81 | 0.047 | 0.094 | 16 | 0.75 | 0.75 | 0.5 | 12 | 8 | 32 | 3 | 0.125 * | ||
| GX86 | SRR8523129 | Yulin | 2018 | Sepsis | ICESsuGX81 | 0.064 | 0.064 | 16 | >256 | >256 | >256 | >1024 | 8 | >1024 | 3 | 0.25 * | ||
| GX28 | SRR8523139 | Yulin | 2013 | Sepsis | ICESsuGX81 | 0.047 | 0.064 | 16 | >256 | >256 | >256 | >1024 | 8 | >1024 | 4 | 0.75 * | ||
| GX95 | SRR8523128 | / | 2013 | / | ICESsuGX81 | 0.047 | 0.064 | 24 | >256 | >256 | >256 | >1024 | 6 | >1024 | 2 | 0.19 * | ||
| GX51 | SRR8523120 | Yulin | 2015 | Sepsis | ICESsuGX81 | 0.047 | 0.047 | 16 | >256 | >256 | >256 | >1024 | 2 | >1024 | 8 | 0.75 * | ||
| GX64 | SRR8523119 | Yulin | 2016 | / | ICESsuGX81 | 0.094 | 0.064 | 16 | >256 | >256 | >256 | >1024 | 12 | >1024 | 6 | 0.75 * | ||
| GX84 | SRR8523116 | Guilin | 2017 | / | ICESsuGX81 | 0.064 | 0.064 | 16 | >256 | >256 | >256 | >1024 | 8 | >1024 | 3 | 0.5 * | ||
| GX97 | SRR8523126 | / | 2018 | / | ICESsuGX81 | 0.047 | 0.064 | 16 | >256 | >256 | >256 | >1024 | 4 | >1024 | 1.5 | 0.38 * |
Abbreviations: PEN G = Penicillin G; CEF = Cefaclor; TET = Tetracycline; ERY = Erythromycin; AZI = Azithromycin; CLI = Clindamycin; STR = Streptomycin; KAN = Kanamycin; SPE = Spectinomycin; GEN = Gentamicin; TRI = Trimethoprim*-sulfamethoxazole (1/19) *: MIC value of Trimethoprim.